Excerpt from: Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
Excerpt from: Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
See the original post: Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
Read the rest here: Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
More: Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Go here to read the rest: Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
Continued here: Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
Read this article: Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
Read more: NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
See the original post: Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Go here to read the rest: Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual...
Recent Comments